Biomedical
These projects build on the multi-functionality allowed by 2DMs to demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-) sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) which allows for continuous health monitoring and built-in pharmacological interventions.
The aim is to offer new technology solutions exploiting the unique properties of 2D materials (2DM) that would reduce cost and increase the efficacy of diagnostics or therapies, or provide new diagnostics or therapies for which there is currently no solution. It would strengthen Europe’s industrial position in, early diagnostics, disease prediction and prevention, disease monitoring and reducing hospitalization time.
Projects
Latest articles
Graphene oxide added to the composition of the liquid artificial retina: A further step toward clinical trials
Graphene Flagship partner, the Istituto Italiano di Tecnologia, together with IRCCS Azienda Ospedaliera Metropolitana – Policlinico San Martino Hospital, has demonstrated that graphene oxide—used for the first time in the ophthalmic field—enhances the liquid artificial retina, increasing light sensitivity and recovery of visual function in advanced stages of retinitis pigmentosa. The study, published in Nature Communications, led to the restoration of electrical activity in the visual cortex, bringing this strategy closer to future clinical trials in humans.
Spotlight: Teissir Ben Ammar
Bridging the gap between today’s proven advances and real, market-ready solutions.
